Oslo, 27 June 2025

The annual general meeting of Observe Medical ASA (the "Company" or "Observe Medical", Euronext Expand ticker "OBSRV") was held today, on 27 June 2025 at 10:00 hours (CEST), at Dronning Eufemias gate 16, 2nd floor, 0191 Oslo, Norway.

All resolutions were made in accordance with the proposals from the board of directors and the nomination committee.

The minutes from the general meeting is attached hereto and will also be available at www.observemedical.com.

As set out in the minutes, the general meeting has resolved to reduce the Company's share capital by way of reducing the nominal value of each share with NOK 3.48, from NOK 3.90 to NOK 0.42. Following the share capital reduction, the Company's share capital will be NOK 8,088,533.04, divided into 19,258,412 shares, each with a nominal value of NOK 0.42.

For further information, please contact:

Jørgen Mann, CEO Observe Medical

Mobile: +45 408 67 558

E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical

Mobile: +47 958 12 765

E-mail: johan.fagerli@observemedical.com

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

About Observe Medical: 

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and commercialisation of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.